Dexcom (DXCM) Cash & Equivalents (2010 - 2026)
Dexcom (DXCM) posted quarterly Cash & Equivalents of $1.1 billion for Q2 2026, down 4.66% year-over-year from $1.2 billion in Q2 2025, and down 1.18% quarter-over-quarter from $1.1 billion in Q1 2026.
Dexcom (DXCM) Cash & Equivalents (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Cash & Equivalents for 17 consecutive years, with $1.1 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash & Equivalents fell 4.66% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $1.1 billion (down 4.66% YoY), while the FY2025 annual figure was $917.7 million, up 51.41% from the prior year.
- Cash & Equivalents slipped to $1.1 billion in Q2 2026 per DXCM's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Cash & Equivalents topped out at $1.8 billion in Q3 2025 and bottomed at $566.3 million in Q4 2023.
- Historically, Cash & Equivalents has averaged $882.1 million across 5 years, with a median of $793.3 million in 2022.
- Annual changes were most pronounced in 2022 — Cash & Equivalents slumped 51.67% — and 2025, when it jumped 195.51%.
- Dexcom's Cash & Equivalents stood at $642.3 million in 2022, then dropped by 11.83% to $566.3 million in 2023, then advanced by 7.03% to $606.1 million in 2024, then surged by 51.41% to $917.7 million in 2025, then climbed by 20.41% to $1.1 billion in 2026.
- Business Quant data shows DXCM's Cash & Equivalents at $1.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $917.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Bn |
| Mar 31, 2026 | 1.12 Bn |
| Dec 31, 2025 | 917.70 Mn |
| Sep 30, 2025 | 1.37 Bn |
| Jun 30, 2025 | 1.16 Bn |
| Mar 31, 2025 | 904.90 Mn |
| Dec 31, 2024 | 134.20 Mn |
| Sep 30, 2024 | 621.20 Mn |
| Jun 30, 2024 | 939.20 Mn |
| Mar 31, 2024 | 851.20 Mn |
| Dec 31, 2023 | 566.30 Mn |
| Sep 30, 2023 | 643.70 Mn |
| Jun 30, 2023 | 1.19 Bn |
| Mar 31, 2023 | 623.20 Mn |
| Dec 31, 2022 | 642.30 Mn |
| Sep 30, 2022 | 698.10 Mn |
| Jun 30, 2022 | 735.40 Mn |
| Mar 31, 2022 | 716.00 Mn |
| Dec 31, 2021 | 1.05 Bn |
| Sep 30, 2021 | 1.44 Bn |